Microplastics, Nanoplastics, and Inflammatory Bowel Disease (with Manasi Agrawal)

Item: Microplastics, Nanoplastics, and Inflammatory Bowel Disease (with Manasi Agrawal)
Rating: 4
Author: PostSingularity Institute

by Manasi Agrawal, MD, MS

Life & Natural Systems Medicine & Health MMedicine and Nursing MJHGastroenterology

🎙 Manasi Agrawal, MD, MS 👥 551 📅 March 28, 2026 ⏱ 50 min 👁 176 📄 expert opinion 🧭 2026-08-16

Available in: English (current) Français

Keywords

microplasticsnanoplasticsIBDexposomegut microbiome

Summary

In this webinar, Dr. Manasi Agrawal discusses the potential role of microplastics and nanoplastics in inflammatory bowel disease (IBD). She begins by defining IBD and its subtypes, noting the rising incidence globally, particularly in children, and linking this to environmental changes. She introduces the exposome concept and distinguishes between conceptual and actionable exposures. The presentation covers the characteristics of microplastics and nanoplastics, emphasizing the greater harm of nanoplastics due to their size and ability to cross barriers. Methodological challenges in measuring these particles are highlighted, including contamination and detection techniques. Dr. Agrawal reviews key studies, including a landmark NEJM study linking microplastics in carotid plaques to cardiovascular events, and a Chinese study finding higher microplastic levels in IBD patients’ stool. She then presents preliminary data from her own PLANET study, which examines microplastic exposure during pregnancy and early life. Findings include the presence of microplastics in all maternal stool samples, with distinct size distributions in Crohn’s disease patients, suggesting internalization of smaller particles. She also discusses co-pollutants like PFAS and metals, linking them to IBD risk. Finally, she offers practical tips for reducing plastic exposure, such as avoiding non-stick cookware and ultra-processed foods, and highlights potential protective factors like anthocyanins.

200 words

Critical Evaluation

Value of the Information & Strength of the Argument

The presentation provides valuable insights into the emerging field of microplastics and IBD, synthesizing current evidence and presenting novel preliminary data. The argumentation is well-structured, building from basic definitions to complex research findings. Dr. Agrawal carefully distinguishes between established findings and hypotheses, and acknowledges limitations in existing studies. The inclusion of her own research adds originality, though the preliminary nature of the data is appropriately emphasized. The discussion of methodological challenges is particularly valuable for understanding the complexities of this research area.

Scientific Rigor, Source Quality, Title Accuracy

The scientific rigor is high, with references to peer-reviewed studies, including a notable NEJM publication. The speaker is transparent about the limitations of her own pilot data and the need for further research. The title accurately reflects the content, and the presentation stays focused on the topic. The sources cited are credible, and the speaker does not overstate conclusions. The webinar format includes a Q&A session, but no comments are provided for analysis.

170 words

Title / Content Match

The title accurately reflects the content, which focuses on the relationship between microplastics/nanoplastics and IBD.

Quality & Reliability

8/10

The presentation is given by a physician-scientist specializing in environmental gastroenterology, with references to peer-reviewed studies and ongoing research. It includes preliminary data from the speaker's own studies, which are clearly labeled as such. The content is well-structured and acknowledges limitations.

Key Moments

Markers derived by PSI from the transcript: the creator did not define chapters.

Cited Sources

Microplastics and Nanoplastics in Atheromas and Cardiovascular Events — Italian study measuring microplastics in carotid plaques and association with cardiovascular events.
Microplastics in the gut of patients with inflammatory bowel disease — Chinese study comparing microplastic levels in stool of IBD patients and controls.
Rapid single-particle chemical imaging of nanoplastics by SRS microscopy — Study by Columbia researchers detecting nanoplastics in bottled water.

Concurring Sources

Microplastics and human health: A systematic review — Systematic review summarizing evidence on microplastics and health outcomes.

Dissenting Sources

Microplastics in human tissues: A review — Some studies question the clinical significance of microplastics due to methodological limitations and lack of standardized detection methods.

Contribution & Novelties

The webinar provides an up-to-date overview of the emerging evidence linking microplastics and nanoplastics to IBD, with a focus on the exposome framework. Dr. Agrawal presents preliminary data from her PLANET study, which is among the first to examine microplastic exposure during pregnancy and early life in relation to IBD risk. The finding of distinct microplastic size distributions in Crohn’s disease patients is novel and suggests potential mechanisms. The discussion of methodological challenges and the need for plastic-free protocols is a valuable contribution to the field.

Pour aller plus loin :

Exposome — Overview of the exposome concept.
Inflammatory bowel disease — General information on IBD.
Microplastics — Overview of microplastics and their environmental impact.
PFAS — Information on forever chemicals.
Anthocyanins — Overview of anthocyanins and their potential health benefits.

131 words

Radar Profile

The radar profile shows high scores across all dimensions, indicating a well-balanced presentation with substantial information, strong scientific rigor, and appropriate technical depth. The lowest score is in technical level, but it remains adequate for a general audience.

Reliability 8/10